Pioglitazone Tablet
Product Images NDC 0904-7090

4 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 0904-7090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 00

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 00
Pioglitazone 30 mg oral tablets unit dose packaging label by Major Pharmaceuticals. The label shows the product name, strength, dosage form, and quantity of 100 tablets. It includes dispensing instructions, storage conditions, and manufacturer and distributor information along with the NDC number 0904-7096-61 and a barcode.*
FDA Label Image

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 01

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 01
Pioglitazone Tablets, USP 15 mg oral tablets labeled for unit dose packaging by Major Pharmaceuticals. The label indicates pharmacy dispensing instructions, prescription-only status, a count of 100 tablets, and usage warnings including storage conditions and safety precautions.*
FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)
A line graph showing mean change from baseline for HbA1c over 26 weeks in a placebo-controlled dose-ranging study. The x-axis represents weeks (0 to 26), and the y-axis shows mean change values. Four lines represent Placebo, 15 mg, 30 mg, and 45 mg doses, with HbA1c levels decreasing over time for the active doses compared to placebo.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

Chemical Structure (Pioglitazone Str)
Chemical structure diagram of Pioglitazone hydrochloride showing its molecular composition and arrangement of atoms represented with standard chemical notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.